Drug Design:Discovery, Development and Delivery

20,901 views
20,729 views

Published on

3 Comments
27 Likes
Statistics
Notes
  • Dear sir Many thanks for your effort in this valuable presentation, can i ask you to send it for me, please, i need it urgently. MOHAWAHAB2002@YAHOO.COM
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • EXCELLENT
    THANKS AND REGARD'S
    DR ANTHONY MELVIN CRASTO Ph.D
    amcrasto@gmail.com
    MOBILE-+91 9323115463
    GLENMARK SCIENTIST , NAVIMUMBAI, INDIA
    web link
    http://anthonycrasto.jimdo.com/
    http://www.anthonymelvincrasto.yolasite.com/
    http://www.slidestaxx.com/anthony-melvin-crasto-phd
    https://sites.google.com/site/anthonycrastoorganicchemistry/sites---my-own-on-the-net
    http://anthonycrasto.wordpress.com/
    http://organicchemistrysite.blogspot.com/
    http://www.mendeley.com/profiles/anthony-melvin-crasto/
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Fioricet is often prescribed for tension headaches caused by contractions of the muscles in the neck and shoulder area. Buy now from http://www.fioricetsupply.com and make a deal for you.
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Views
Total views
20,901
On SlideShare
0
From Embeds
0
Number of Embeds
115
Actions
Shares
0
Downloads
2,056
Comments
3
Likes
27
Embeds 0
No embeds

No notes for slide

Drug Design:Discovery, Development and Delivery

  1. 1. Drug Design: Discovery, Development and Delivery Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics KLE University BELGAUM – 590010 E-mail: [email_address] Cell No: 0091 9448716277
  2. 2. Drug Design
  3. 3. Drug Design <ul><li>Drug design is the approach of finding drugs by design, based on their biological targets . Typically a drug target is a key molecule involved in a particular metabolic or signalling pathway that is specific to a disease condition or pathology , or to the infectivity or survival of a microbial pathogen . </li></ul><ul><li>Other approaches may be to enhance the normal pathway by promoting specific molecules in the normal pathways that may have been affected in the diseased state. </li></ul><ul><li>In medicine , biotechnology and pharmacology , drug discovery is the process by which drugs are designed </li></ul>
  4. 4. Drug Design <ul><li>1. Rational Drug Design </li></ul><ul><li>2. Computer-assisted Drug Design (CADD) </li></ul><ul><li>3. Neural network in Drug Design </li></ul>
  5. 5. Rational Drug Design <ul><li>The industry now has the research tools to pursue rational Drug Design successfully, but a new hurdle is being raised:finding a way to generate data and manage our knowledge of disease that maximizes the value of that knowledge </li></ul><ul><li>1. Molecular properties </li></ul><ul><li>2. Receptor-Based modeling </li></ul><ul><li>3. Numerical methods </li></ul>
  6. 6. Rational Drug Design Refining the understanding of pathogenesis
  7. 7. Rational Drug Design Investigating complex systems increases knowledge return
  8. 8. Computer-assisted Drug Design (CADD) <ul><li>Drug design is a three-dimensional puzzle where small drug molecules, ligands, are adjusted to the binding site of a protein. </li></ul><ul><li>The factors which affect the protein-ligand interaction can be characterized by using molecular docking and different quantitative structure-activity relationships (QSAR) methods </li></ul>
  9. 9. Computer-assisted Drug Design (CADD) In CoMFA map the colored fields describe how molecular structure can be modified to increase biological activity (CoMFA-Comparative molecular field analysis)
  10. 10. Computer-assisted Drug Design (CADD) <ul><li>The most commonly used tool to model biological system is molecular dynamics </li></ul><ul><li>The model of a receptor refined with molecular dynamics simulations </li></ul>
  11. 11. Computer-assisted Drug Design (CADD) 3D models of membrane receptors can be refined and validated in a realistic lipid-water-salt environment using molecular dynamics simulations
  12. 12. Computer-assisted Drug Design (CADD ) <ul><li>Virtual screening is a computational technique to find novel drug candidates. </li></ul><ul><li>Data from virtual screening can be used to develop predictive models in order to optimize ADMET properties of the candidate molecules. </li></ul><ul><li>The ultimate goal of this procedure is to find investing lead molecules that are worth for further drug research and synthesis. </li></ul>
  13. 13. Computer-assisted Drug Design (CADD) New potent inhibitor for the Human Sirutuin Type 2 enzyme was found using a virtual screening technique
  14. 14. Neural network in Drug Design <ul><li>This is the most latest technique being applied to discover new drugs. It works on the same principles as the neural networks found in the human brain. </li></ul><ul><li>This technique makes use of Computer Artificial Intelligence, whereby a computer learns by itself, how to approach a target drug molecule and improves its iterations by itself. </li></ul><ul><li>This technique can be applied to solve complex drug calculations. Desktop computers as well as Super-Computers both are employed for Neural Networks Drug research. </li></ul>
  15. 15. Applications <ul><li>1 . Find interesting lead molecules quickly </li></ul><ul><li>2. Predicting properties and activities of untested molecules </li></ul><ul><li>3. Propose compounds for synthesis </li></ul><ul><li>4. Validate models of receptor binding sites </li></ul><ul><li>5. Optimize pharmacokinetic properties of compound </li></ul>
  16. 16. Drug Discovery
  17. 17. Drug Discovery <ul><li>In medicine , biotechnology and pharmacology , drug discovery is the process by which drugs are discovered </li></ul><ul><li>The process of drug discovery involves the identification of candidates, synthesis, characterization, screening, and assays for therapeutic efficacy. </li></ul>
  18. 18. Dermatology Inflammatory/ Immune-related Oncology/ Cancer Respiratory Cardiovascular/ Blood Disorder Musculoskeletal Infectious Disease Microbial/Viral Neurological/ Pyschotherapeutic Ophthalmic Metabolic Gastrointestinal Important DRUG Targets Focused Areas of Research
  19. 19. Drug Discovery Pathway Efficacy ADME Toxicology Safety Preformulations Stability Studies Leads Selection of candidate drug Preclinical Studies Primary Screening [Hits] Discovery & Development
  20. 20. <ul><li>1. What is an ideal drug? </li></ul><ul><ul><li>(Given by mouth and has a beneficial effect {safe & efficacious} in only ~ 50% !) </li></ul></ul><ul><li>2. What is a promising drug candidate? </li></ul><ul><ul><li>(Most site specific with best combination of target affinity, highest bioavailability and lowest toxicity) </li></ul></ul><ul><li>3. How is a ‘lead’ drug candidate screened for ideal </li></ul><ul><li>characteristics? </li></ul><ul><ul><li>(Study of the in vitro ADME/Tox- drug transport , absorption, metabolism, etc) </li></ul></ul><ul><ul><ul><li>[Toxicity & pharmacokinetics: In vivo ] </li></ul></ul></ul>Drug Discovery Process
  21. 21. Drug Discovery Pipeline Validated Targets Hot Leads Drug Candidates ADME PK Human Trials H-UHTS Primary Screening Secondary Screening Lead Identification Lead Optimization Pre-clinical Clinical Discovery Development M-HTS Lab & Animal Tests L-MTS Clinical Validation Genome Sequencing SNP Discovery Genotyping Gene Expession Profiling Exploratory Research Genomics Proteomics Drug Discovery Fractionate Protein Mass Spec Combichem Synthesis Natural Compounds Compound Library Pathway Mapping Protein Structure Functional Genomics Protein- protein Interactions Protein Localization Expression Profiling Peptide Mass Fingerprinting Production Diagnostics
  22. 22. Drug Discovery Process Assay Development Discovery Center w/primary & secondary screening & Pre-ADME In vitro & in-vivo ADMET Compound library generation Combichem Clinical Trials & Clinical monitoring Functional and ADMET screening assays becoming more important earlier in the screening process. Exploratory Drug Discovery Drug Development New Drug Target Identification Target Qualification Validation Lead Identification Lead Optimization Preclinical Development Clinical Development NDA
  23. 23. “ Real drug “pipeline ” Drug Targets A – Absorption Solubility Stability Dissolution Drug Transport D - Distribution Plasma Protein Binding assays (PPB) “ Permeability” Drug Drug
  24. 24. Cell Membrane Transport Mechanisms Transcellular Paracellular Active Transport Active Efflux
  25. 25. <ul><li>Membranes are two-dimensional solutions of oriented lipids and globular proteins that are mobile in the plane of the membrane – fluid-mosaic model </li></ul><ul><li>Membrane transport is mediated by specific integral membrane proteins – ion channels, porins, transporters ( passive ), pumps ( active ) </li></ul><ul><li>Integral membrane proteins have common structural features – predominantly transmembrane  helices </li></ul>Membrane structure & transport
  26. 26. Ion channels are membrane spanning proteins
  27. 27. Opening and closing of channels requires conformational change
  28. 28. Extracellular Intracellular Flux of ions through the channels is passive
  29. 29. Drug Development
  30. 30. Drug Development <ul><li>Drug development or preclinical development is defined in many pharmaceutical companies as the process of taking a new chemical lead through the stages necessary to allow it to be tested in human clinical trials , although a broader definition would encompass the entire process of drug discovery and clinical testing of novel drug candidates. </li></ul>
  31. 31. Drug Discovery Pathway Efficacy ADME Toxicology Safety Preformulations Stability Studies Leads Selection of candidate drug Preclinical Studies Primary Screening [Hits] Discovery & Development
  32. 32. Drug Development Process
  33. 33. Reasons for Attrition in Drug Development
  34. 34. Stomach pH2 Intestine pH3-8 PV Blood Kidneys Tissues Cell Target Stability Acidic buffer Stability Acidic enzymatic buffer Solubility pKa Stability CYP3A metabolic stability Permeability Passive P-gp efflux Transportes Log D Liver Phase I and II Metabolic stability Metabolite ID Protein binding RBC uptake Stability Enzymatic Plasma stability Renal Extraction Log D Permeability Passive Transporters Log D Cell Exposure Barriers of Drug Reaching Target
  35. 35. Candidate Selection: Building “Developability” in Preclinical Profiling Lead (active molecule) Metabolism Selectivity Potency LO (optimized molecule) Potency Selectivity Metabolism Physical properties Best leads Physical / chemical properties Biopharmaceutics
  36. 36. Stability in Physiological Conditions Duodenum Stomach Ascending colon Descending colon Jejunum Ileum Small intestine Transverse colon Rectum pH = 1 - 3.5 pH = 5 - 7 pH = 8 Blood = 7.4
  37. 37. Solubility, Permeability, Chemical and Metabolic Stability Affects Oral Bioavailability Solid Drug Drug in Solution Absorbed Drug Dissolution Membrane Transfer Solubility Permeability Systemic Circulation Metabolism Liver Extraction Portal Vein
  38. 38. Physico-chemical profile of NCEs Permeability pKa Stability PPB Log D Polymorphism Lipophilicity Solubility Integrity Profile
  39. 39. Successful Drug = Activity + Property Optimization Activity Pharmacology Property Pharmaceutical Profiling In vitro Solubility Permeability BBB & Pgp Log P & pKa Metabolism P450 Inhibition Stability Pharmacokinetics In vivo Enzyme Receptor Cell-based assay In vitro Animal Model In vivo Redesign
  40. 40. Drug Development Process
  41. 41. Drug Delivery
  42. 42. Drug Delivery <ul><li>Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals </li></ul><ul><li>Drug Delivery technologies are patent protected formulation technologies that modifies drug release profile, absorption, distribution and elimination for the benefit of improving product efficacy & safety and patient convenience & compliance </li></ul>
  43. 43. Drug Delivery <ul><li>Most common methods of delivery include the preferred non-invasive peroral (through the mouth), topical (skin), transmucosal ( nasal , buccal / sublingual , vaginal , ocular and rectal ) and inhalation routes </li></ul>
  44. 44. Drug Delivery <ul><li>Many medications such as peptide and protein , antibody , vaccine and gene based drugs, in general may not be delivered using these routes because they might be susceptible to enzymatic degradation or can not be absorbed into the systemic circulation efficiently due to molecular size and charge issues to be therapeutically effective </li></ul><ul><li>protein and peptide drugs have to be delivered by injection . </li></ul>
  45. 45. Drug Delivery <ul><li>Current efforts in the area of drug delivery include the development of targeted delivery in which the drug is only active in the target area of the body (for example, in cancerous tissues) and in which the drug is released over a period of time in a controlled manner from a formulate </li></ul>
  46. 46. Context – Drug Delivery
  47. 47. Context – Drug Delivery
  48. 48. Drug Delivery - Markets
  49. 49. Drug Delivery Systems Nano Technology DDS Buccal DDS Rectal DDS Vaginal DDS Pulmonary DDS Nasal DDS Topical DDS Parentral DDS Oral DDS Delivery Systems
  50. 50. Thanx for your …..

×